|
Volumn 9, Issue 18, 2002, Pages 1701-1716
|
DNA-binding antitumor agents: From pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [3 (DIMETHYLAMINO)PROPYL] 9 METHOXY 5 NITRO 2,6 DIHYDROPYRAZOLO[3,4,5 KL]ACRIDINE;
3 [3 (DIMETHYLAMINO)PROPYL] 10 METHOXY 6 NITRO 2,7 DIHYDRO 3H PYRIMIDO[4,5,6 KL]ACRIDINE 2 THIONE;
ACRIDINE DERIVATIVE;
AMSACRINE;
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
FLUOROURACIL;
IMIDAZOACRIDONE;
MITONAFIDE;
MITOXANTRONE;
N4 [2 (DIMETHYLAMINO)ETHYL 1 [2 (DIMETHYLAMINO)ETHYL] AMINO 4 ACRIDINECARBOXAMIDE;
N4 [2 (DIMETHYLAMINO)ETHYL 4 ACRIDINECARBOXAMIDE;
N4 [OMEGA (AMINO)ALKYL 1 [[OMEGA (AMINO)ALKYL]AMINO] 4 ACRIDINE 4 CARBOXAMIDE DERIVATIVE;
N4 [OMEGA (AMINO)ALKYL 1 [[OMEGA (AMINO)ALKYL]AMINO] 4 ACRIDINECARBOXAMIDE DERIVATIVE;
N4 [OMEGA (AMINO)ALKYL 1 [[OMEGA (AMINO)ALKYL]AMINO] 4 ACRIDONE 4 CARBOXAMIDE DERIVATIVE;
PYRAZOLO[3,4,5 KL]ACRIDINE 5 CARBOXAMIDE DERIVATIVE;
PYRIMIDO[4,5,6 KL]ACRIDINE DERIVATIVE;
PYRIMIDO[5,6,1 DE]ACRIDINE DERIVATIVE;
TRIAZOLOACRIDONE;
UNCLASSIFIED DRUG;
DNA;
PYRIMIDINE DERIVATIVE;
ANIMAL CELL;
CHROMATOPHORE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DNA BINDING;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
MOUSE;
NONHUMAN;
REVIEW;
ANIMAL;
CHEMISTRY;
METABOLISM;
STRUCTURE ACTIVITY RELATION;
ACRIDINES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DNA;
DRUG DESIGN;
HUMANS;
PYRIMIDINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0036024724
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867023369268 Document Type: Review |
Times cited : (39)
|
References (42)
|